UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 To
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2012
Commission file number: 000-54672
AMERICAN CRYOSTEM CORPORATION
(Name of registrant as specified in its charter)
| Nevada | 26-4574088 | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|
1 Meridian Road, Eatontown, NJ 07724 |
| (Address of principal executive offices)(Zip Code) |
(732) 747-1007
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes S No £
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes S No £
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer £ | Accelerated filer £ |
|
Non-accelerated filer £ (Do not check if smaller reporting company) |
Smaller reporting company S |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
Yes £ No S
As of August 28, 2012, there were 29,949,362 shares of common stock outstanding.
EXPLANATORY NOTE
The sole purpose of this Amendment No. 1 to American CryoStem Corporation’s Quarterly Report on Form 10-Q (the “Form 10-Q”) for the period ended June 30, 2012, as filed with the Securities and Exchange Commission on August 20, 2012, is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 provides the financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).
No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.
PART II - OTHER INFORMATION
| ITEM 6. | EXHIBITS |
| Exhibit No. | Description |
| (a) | Documents furnished as Exhibits hereto: |
| 101. INS | XBRL Instance Document (2) |
| 101. SCH | XBRL Taxonomy Extension Schema Document (2) |
| 101. CAL | XBRL Taxonomy Extension Calculation Linkbase Document (2) |
| 101. DEF | XBRL Taxonomy Extension Definition Linkbase Document (2) |
| 101. LAB | XBRL Taxonomy Extension Label Linkbase Document (2) |
| 101. PRE | XBRL Taxonomy Extension Presentation Linkbase Document (2) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| AMERICAN CRYOSTEM CORPORATION | ||
| September 6, 2012 | By: | /s/ John Arnone |
| John Arnone, Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| September 6, 2012 | By: | /s/ Anthony Dudzinski |
| Anthony Dudzinski, Treasurer | ||
| (Principal Financial Officer) | ||